Conference Details - Faculty

View all Conferences

Continuing Education Information

Physicians: Physicians’ Education Resource is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians’ Education Resource designates this educational activity for a maximum of 29 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Physician Assistants: AAPA accepts category 1 credit from AOACCME, Prescribed credit from AAFP, and AMA category 1 CME credit for the PRA from organizations accredited by the ACCME.

14th Annual International Congress on Hematologic Malignancies

The Fairmont Château Whistler
Whistler
March 17-21, 2010

Program Director

Andrew D. Zelenetz, MD, PhD
Chief, Lymphoma Service
Department of Medicine
Memorial Sloan-Kettering Cancer Center
Associate Professor of Medicine
Weill Cornell Medical College
New York, USA

Planning Committee

John C. Byrd, MD
D. Warren Brown Professor of Leukemia Research
Professor of Medicine and Medical Chemistry
Interim Co-Director, Division of Hematology and Oncology
Associate Director, Translational Research
The Ohio State University Comprehensive Cancer Center
Columbus, USA

Sundar Jagannath, MD
Professor of Medicine
New York Medical College
Chief, Multiple Myeloma and Transplant Program
St. Vincent’s Comprehensive Cancer Center
New York, USA

John P. Leonard, MD
The Richard T. Silver Distinguished Professor of Hematology and Medical Oncology
Weill Cornell Medical College
Director, Clinical Research
Division of Hematology/Oncology
New York Weill Cornell Medical Center
Attending Physician
NewYork-Presbyterian Hospital
New York, USA

Charles Schiffer, MD
Professor of Medicine and Oncology
Karmanos Cancer Institute 
Wayne State University School of Medicine
Detroit, USA

Faculty

Jennifer R. Brown, MD, PhD
Assistant Professor of Medicine
Harvard Medical School
Attending Physician
Lymphoma Program
Dana-Farber Cancer Institute
Boston, USA

Joseph M. Connors, MD
Clinical Director, Centre for Lymphoid Cancer
British Columbia Cancer Agency
University of British Columbia
Vancouver, Canada

Jorge Cortes, MD
Professor of Medicine
Chief, CML Section
Deputy Chair, Department of Leukemia
The University of Texas M. D. Anderson Cancer Center
Houston, USA

Harry Erba, MD, PhD
Associate Professor of Internal Medicine
University of Michigan Health System
Ann Arbor, USA

Andrew M. Evens, DO, MSc
Assistant Professor of Medicine
Feinberg School of Medicine
Northwestern University
Director, Translational Therapeutics
Division of Hematology/Oncology
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Chicago, USA

Alessandra Ferrajoli, MD
Assistant Professor of Medicine
Department of Leukemia
The University of Texas M. D. Anderson Cancer Center
Houston, USA

Randy Gascoyne, MD
Clinical Professor of Pathology
British Columbia Cancer Agency
University of British Columbia
Vancouver, Canada

Morie Gertz, MD
Professor of Medicine
Chair, Department of Internal Medicine
Mayo Clinic Rochester
Rochester, USA

Paul Hamlin, MD
Assistant Member Attending
Medical Oncology
Lymphoma Service
Memorial Sloan-Kettering Cancer Center
Assistant Professor of Medicine
Department of Medicine
Joan & Sanford I. Weill Medical College of Cornell University
NewYork-Presbyterian Hospital
New York, USA

Steven M. Horwitz, MD
Assistant Attending Physician
Department of Medicine
Division of Hematologic Oncology–Lymphoma
Memorial Sloan-Kettering Cancer Center
New York, USA

Jeffrey Jones, MD, MPH
Assistant Professor of Internal Medicine
Division of Hematology/Oncology
The Ohio State University Comprehensive Cancer Center
Columbus, USA

Youn Kim, MD
Joanne and Peter Haas Jr Professor for Cutaneous Lymphoma Research
Director, Multidisciplinary Cutaneous Lymphoma Program
Stanford Cancer Center
Stanford, USA

Thomas James Kipps, MD, PhD
Professor of Medicine
Deputy Director, Research Operations
Moores UCSD Cancer Center
La Jolla, USA

Ronald Levy, MD
Professor and Chief, Division of Oncology
Stanford University School of Medicine
Stanford, USA

Sagar Lonial, MD
Associate Professor
Emory University School of Medicine
Director, Translational Research
B-Cell Malignancy Program
Emory Winship Cancer Institute
Atlanta, USA

David Maloney, MD, PhD
Associate Member, Clinical Research Division
Fred Hutchinson Cancer Research Center
Associate Professor of Medicine
Division of Oncology
University of Washington
Seattle, USA

Ruben A. Mesa, MD
Professor of Medicine
Consultant of Hematology and Oncology
Mayo Clinic
Scottsdale, USA

Jerald P. Radich, MD
Medical Director, Research Trials Office
Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance
Professor
University of Washington School of Medicine
Seattle, USA

Donna Reece, MD
Director, Program for Multiple Myeloma and Related Disease
Associate Professor of Medicine
Princess Margaret Hospital
Toronto, Canada

G. David Roodman, MD, PhD
Professor of Medicine
Vice Chair, Research
Department of Medicine
University of Pittsburgh School of Medicine
Director, Bone Biology Center
University of Pittsburgh Medical Center
Director, Myeloma Program
University of Pittsburgh Cancer Institute
VA Pittsburgh Healthcare System
Pittsburgh, USA

Wayne A. Rosenkrans, Jr, PhD
Chairman and President
Personalized Medicine Coalition
Washington, USA
Chief Applications Officer
SciTech Strategies
Berwyn, USA
Vice President, Strategic Consulting
Fuld & Company
Distinguished Fellow
MIT Center for Biomedical Innovation
Cambridge, USA

Sonali M. Smith, MD
Associate Professor
Associate Director, Lymphoma Program
Section of Hematology/Oncology
Department of Medicine
The University of Chicago
Chicago, USA

David Steensma, MD
Associate Professor of Medicine
Harvard Medical School
Department of Hematological Malignancies
Dana-Farber Cancer Institute
Boston, USA

Keith Stewart, MD
Professor of Medicine
Consultant
Division of Hematology/Oncology
College of Medicine, Mayo Clinic
Scottsdale, USA

Martin S. Tallman, MD
Professor of Medicine
Associate Chief, Division of Hematology/Oncology
Feinberg School of Medicine
Northwestern University
Co-Director, Hematologic Malignancies Program
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Chicago, USA

William G. Wierda, MD, PhD
Associate Professor of Medicine and Internist
Department of Leukemia
The University of Texas M. D. Anderson Cancer Center
Houston, USA

Michael Williams, MD
Byrd S. Leavell Professor, Internal Medicine and Pathology
Division of Hematology/Oncology
The University of Virginia Health System
Charlottesville, USA

Wyndham H. Wilson, MD, PhD
Senior Investigator and Chief, Lymphoma Therapeutics
Metabolism Branch
Chief, Lymphoma Clinic
Medicine Branch
Center for Cancer Research
National Cancer Institute, National Institutes of Health
Bethesda, USA

Jane Winter, MD
Professor of Medicine
Division of Hematology/Oncology
Feinberg School of Medicine
Northwestern University
Member
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Chicago, USA

Clive S. Zent, MD
Associate Professor of Medicine
Consultant, Hematology
Mayo Clinic
Rochester, USA

Jeffrey Zonder, MD
Assistant Professor of Medicine
Division of Hematology-Oncology
Karmanos Cancer Institute
Wayne State University School of Medicine
Detroit, USA

Educational Grants

An educational grant for this activity was provided by:


  1. Genentech BioOncology/
    Biogen Idec
  3. Cephalon Oncology
  5. Allos Therapeutics
  6. Bristol-Myers Squibb
  7. Eisai, Inc.
  8. Merck Oncology
  9. Novartis Oncology
  11. Lilly USA, LLC